Navigation Links
Reportlinker Adds Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015
Date:11/18/2009

NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

http://www.reportlinker.com/p0164632/Global-In-Vitro-Diagnostics-Investment-Opportunities-Analysis-and-Forecasts-to-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

Description

Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for key information and data relating to global in vitro diagnostics market. The report provides global and country level, detailed and comprehensive coverage of market and category revenue, distribution and company share information. It also provides company profiles, pipeline products, news and financial deals in the global in vitro diagnostics market.

Scope

- This report provides detailed data on country-wise market size in countries such as United States, Germany, United Kingdom, France, Italy, Spain, Japan, Canada, China, India, Australia, Brazil.

- It provides data on market size by value for in the categories in in vitro diagnostics devices market such as In Vitro Diagnostics, Clinical Chemistry Test Reagents, Immunochemistry Test Reagents, Blood Test Reagents, Microbiology Test Reagents, Infectious Immunology, Test Reagents, Genetic Test Reagents, Self Testing, and Instruments.

- It gives key company share information for leading competitors, revenues by distribution channel and forecasts of market values at global and country level.

- It also provides overview of the market structure, key trends, drivers and restraints, future outlook, competitive landscape and key developments.

- All figures are based on rigorous research methodologies including in-depth primary and secondary research.

Reasons to buy

- A single source to fulfill all of your business and competitor intelligence needs

- Gain a strong understanding of the in vitro diagnostics devices market at a global level, with break downs for 12 countries

- Evaluate and compare the attractiveness of the market in different geographies.

- Identify growth segments and opportunities in the industry.

- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched.

- Analyze the competitiveness of the market in different countries and regions and identify hotspots.

- Develop strategies based on the latest product, brand, expansion and research and development news.

- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market.

- Identify and analyze the strengths and weaknesses of the industry incumbents.

Companies Mentioned

F. Hoffmann-La Roche Ltd.

Siemens Healthcare

Sysmex Corporation

Abbott Laboratories

Beckman Coulter, Inc.

Ortho-Clinical Diagnostics Inc.

OLYMPUS CORPORATION

Qiagen N.V.

bioMerieux S.A.

Bio-Rad Laboratories, Inc.

Phadia AB

DiaSorin S.p.A

Becton, Dickinson and Company

Gen-Probe Incorporated

Inverness Medical Innovations, Inc.

Ventana Medical Systems, Inc.

Hologic, Inc.

Dade Behring Holdings, Inc.

Calypte Biomedical Corporation

CytoCore, Inc.

Daxor Corporation

IRIS International, Inc.

Onconome, Inc.

Streck, Inc.

Targeted Diagnostics & Therapeutics, Inc.

Biovest International, Inc.

Biomeda Corp.

Quidel Corporation

American Bio Medica Corporation

AMPCOR Technologies, Inc.

Laboratory Corporation of America Holdings

American Diagnostica Inc.

GRANT Life Sciences, Inc.

Luminex Corporation

Akonni Biosystems Inc

Progentech USA, Inc.

Source MDx

GeneWorks Pty. Ltd.

Astral Scientific Pty Ltd

Eiken Chemical Co.,Ltd.

Cosmo Bio Co., Ltd.

Techno Medica Co., Ltd.

China Medical Technologies, Inc.

Beijing Pason Pharmaceuticals Inc.

Jingmei Biotech Co.,Ltd.

Beijing Bio-Ekon Biotechnology Co., Ltd.

China Sky One Medical, Inc

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

3 Definitions of the Markets Covered in the Report

3.1 In Vitro Diagnostics

3.2 Clinical Chemistry

3.3 Genetic Testing

3.4 Haematology

3.5 Histology And Cytology

3.6 Immuno Chemistry

3.7 Infectious Immunology

3.8 Microbiology Culture

4 Global In Vitro Diagnostics

4.1 In Vitro Diagnostics, Global, Overall Revenue ($ mn), 2000-2015

4.2 In Vitro Diagnostics, Global, Company Share (2007-2008)

5 In Vitro Diagnostics In United States

5.1 In Vitro Diagnostics, United States, Overall Revenue ($ mn), 2000-2015

5.2 In Vitro Diagnostics, United States, Distribution Share (2007-2008)

5.3 In Vitro Diagnostics, United States, Company Share (2007-2008)

6 In Vitro Diagnostics In Japan

6.1 In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015

6.2 In Vitro Diagnostics, Japan, Distribution Share (2007-2008)

6.3 In Vitro Diagnostics, Japan, Company Share (2007-2008)

7 In Vitro Diagnostics In Germany

7.1 In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015

7.2 In Vitro Diagnostics, Germany, Distribution Share (2007-2008)

7.3 In Vitro Diagnostics, Germany, Company Share (2007-2008)

8 In Vitro Diagnostics In Italy

8.1 In Vitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015

8.2 In Vitro Diagnostics, Italy, Distribution Share (2007-2008)

8.3 In Vitro Diagnostics, Italy, Company Share (2007-2008)

9 In Vitro Diagnostics In France

9.1 In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015

9.2 In Vitro Diagnostics, France, Distribution Share (2007-2008)

9.3 In Vitro Diagnostics, France, Company Share (2007-2008)

10 In Vitro Diagnostics In China

10.1 In Vitro Diagnostics, China, Overall Revenue ($ mn), 2000-2015

10.2 In Vitro Diagnostics, China, Distribution Share (2007-2008)

10.3 In Vitro Diagnostics, China, Company Share (2007-2008)

11 In Vitro Diagnostics In Spain

11.1 In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015

11.2 In Vitro Diagnostics, Spain, Distribution Share (2007-2008)

11.3 In Vitro Diagnostics, Spain, Company Share (2007-2008)

12 In Vitro Diagnostics In United Kingdom

12.1 In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015

12.2 In Vitro Diagnostics, United Kingdom, Distribution Share (2007-2008)

12.3 In Vitro Diagnostics, United Kingdom, Company Share (2007-2008)

13 In Vitro Diagnostics In Brazil

13.1 In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), 2000-2015

13.2 In Vitro Diagnostics, Brazil, Distribution Share (2007-2008)

13.3 In Vitro Diagnostics, Brazil, Company Share (2007-2008)

14 In Vitro Diagnostics In Canada

14.1 In Vitro Diagnostics, Canada, Overall Revenue ($ mn), 2000-2015

14.2 In Vitro Diagnostics, Canada, Distribution Share (2007-2008)

14.3 In Vitro Diagnostics, Canada, Company Share (2007-2008)

15 In Vitro Diagnostics In India

15.1 In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015

15.2 In Vitro Diagnostics, India, Distribution Share (2007-2008)

15.3 In Vitro Diagnostics, India, Company Share (2007-2008)

16 In Vitro Diagnostics In Australia

16.1 In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015

16.2 In Vitro Diagnostics, Australia, Distribution Share (2007-2008)

16.3 In Vitro Diagnostics, Australia, Company Share (2007-2008)

17 Overview of Key Companies in Global In Vitro Diagnostics Market

17.1 F. Hoffmann-La Roche Ltd.

17.2 Siemens Healthcare

17.3 Sysmex Corporation

17.4 Abbott Laboratories

17.5 Beckman Coulter, Inc.

17.6 Ortho-Clinical Diagnostics Inc.

17.7 OLYMPUS CORPORATION

17.8 Qiagen N.V.

17.9 bioMerieux S.A.

17.10 Bio-Rad Laboratories, Inc.

17.11 Phadia AB

17.12 DiaSorin S.p.A

17.13 Becton, Dickinson and Company

17.14 Gen-Probe Incorporated

17.15 Inverness Medical Innovations, Inc.

17.16 Ventana Medical Systems, Inc.

17.17 Hologic, Inc.

17.18 Dade Behring Holdings, Inc.

17.19 Calypte Biomedical Corporation

17.20 CytoCore, Inc.

17.21 Daxor Corporation

17.22 IRIS International, Inc.

17.23 Onconome, Inc.

17.24 Streck, Inc.

17.25 Targeted Diagnostics & Therapeutics, Inc.

17.26 Biovest International, Inc.

17.27 Biomeda Corp.

17.28 Quidel Corporation

17.29 American Bio Medica Corporation

17.30 AMPCOR Technologies, Inc.

17.31 Laboratory Corporation of America Holdings

17.32 American Diagnostica Inc.

17.33 GRANT Life Sciences, Inc.

17.34 Luminex Corporation

17.35 Akonni Biosystems Inc

17.36 Progentech USA, Inc.

17.37 Source MDx

17.38 GeneWorks Pty. Ltd.

17.39 Astral Scientific Pty Ltd

17.40 Eiken Chemical Co.,Ltd.

17.41 Cosmo Bio Co., Ltd.

17.42 Techno Medica Co., Ltd.

17.43 China Medical Technologies, Inc.

17.44 Beijing Pason Pharmaceuticals Inc.

17.45 Jingmei Biotech Co.,Ltd.

17.46 Beijing Bio-Ekon Biotechnology Co., Ltd.

17.47 China Sky One Medical, Inc.

18 Financial Deals Landscape

18.1 Merger

18.2 Acquisition

18.3 Partnerships

19 Recent Developments

19.1 Strategy And Business Planning

19.2 Legal and Regulatory

19.3 Government and Public Interest

19.4 Other Significant Developments

20 Appendix

20.1 Global Markets Direct Research Methodology

20.2 Secondary Research

20.3 Primary Research

20.4 Models

20.5 Forecasts

20.6 Expert Panel Validation

20.7 Currency Conversion

20.8 Contact Us

20.9 Disclaimer

List of Tables

1.1 List of Tables

Table 1: In Vitro Diagnostics, Global, Overall Revenue ($ mn), 2000-2015 37

Table 2: Global In Vitro Diagnostics Market, Cross- Category Analysis, 2000-2015 38

Table 3: In Vitro Diagnostics, Global, Overall Revenue ($ mn), Historic, 2000-2008 40

Table 4: In Vitro Diagnostics, Global, Overall Revenue ($ mn), Forecast, 2008-2015 42

Table 5: In Vitro Diagnostics, Global, Company Share by Revenue ($ mn), 2007-2008 43

Table 6: In Vitro Diagnostics, United States, Overall Revenue ($ mn), 2000-2015 44

Table 7: In Vitro Diagnostics, United States, Overall Revenue ($ mn), Historic, 2000-2008 46

Table 8: In Vitro Diagnostics, United States, Overall Revenue ($ mn), Forecast, 2008-2015 48

Table 9: Clinical Chemistry, United States, Distribution Share by Revenue ($mn), 2007-2008 49

Table 10: Genetic Testing, United States, Distribution Share by Revenue ($mn), 2007-2008 49

Table 11: Haematology, United States, Distribution Share by Revenue ($mn), 2007-2008 50

Table 12: Histology And Cytology, United States, Distribution Share by Revenue ($mn), 2007-2008 50

Table 13: Immuno Chemistry, United States, Distribution Share by Revenue ($mn), 2007-2008 51

Table 14: Infectious Immunology, United States, Distribution Share by Revenue ($mn), 2007-2008 51

Table 15: Microbiology Culture, United States, Distribution Share by Revenue ($mn), 2007-2008 52

Table 16: In Vitro Diagnostics, United States, Company Share by Revenue ($ mn), 2007-2008 53

Table 17: Clinical Chemistry, United States, Company Share by Revenue ($ mn), 2007-2008 54

Table 18: Genetic Testing, United States, Company Share by Revenue ($ mn), 2007-2008 55

Table 19: Haematology, United States, Company Share by Revenue ($ mn), 2007-2008 56

Table 20: Histology And Cytology, United States, Company Share by Revenue ($ mn), 2007-2008 57

Table 21: Immuno Chemistry, United States, Company Share by Revenue ($ mn), 2007-2008 59

Table 22: Infectious Immunology, United States, Company Share by Revenue ($ mn), 2007-2008 61

Table 23: Microbiology Culture, United States, Company Share by Revenue ($ mn), 2007-2008 62

Table 24: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), 2000-2015 63

Table 25: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Historic, 2000-2008 65

Table 26: In Vitro Diagnostics, Japan, Overall Revenue ($ mn), Forecast, 2008-2015 67

Table 27: Clinical Chemistry, Japan, Distribution Share by Revenue ($mn), 2007-2008 68

Table 28: Genetic Testing, Japan, Distribution Share by Revenue ($mn), 2007-2008 68

Table 29: Haematology, Japan, Distribution Share by Revenue ($mn), 2007-2008 69

Table 30: Histology And Cytology, Japan, Distribution Share by Revenue ($mn), 2007-2008 69

Table 31: Immuno Chemistry, Japan, Distribution Share by Revenue ($mn), 2007-2008 70

Table 32: Infectious Immunology, Japan, Distribution Share by Revenue ($mn), 2007-2008 70

Table 33: Microbiology Culture, Japan, Distribution Share by Revenue ($mn), 2007-2008 71

Table 34: In Vitro Diagnostics, Japan, Company Share by Revenue ($ mn), 2007-2008 72

Table 35: Clinical Chemistry, Japan, Company Share by Revenue ($ mn), 2007-2008 73

Table 36: Genetic Testing, Japan, Company Share by Revenue ($ mn), 2007-2008 74

Table 37: Haematology, Japan, Company Share by Revenue ($ mn), 2007-2008 75

Table 38: Histology And Cytology, Japan, Company Share by Revenue ($ mn), 2007-2008 76

Table 39: Immuno Chemistry, Japan, Company Share by Revenue ($ mn), 2007-2008 78

Table 40: Infectious Immunology, Japan, Company Share by Revenue ($ mn), 2007-2008 80

Table 41: Microbiology Culture, Japan, Company Share by Revenue ($ mn), 2007-2008 81

Table 42: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), 2000-2015 82

Table 43: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Historic, 2000-2008 84

Table 44: In Vitro Diagnostics, Germany, Overall Revenue ($ mn), Forecast, 2008-2015 86

Table 45: Clinical Chemistry, Germany, Distribution Share by Revenue ($mn), 2007-2008 87

Table 46: Genetic Testing, Germany, Distribution Share by Revenue ($mn), 2007-2008 87

Table 47: Haematology, Germany, Distribution Share by Revenue ($mn), 2007-2008 88

Table 48: Histology and Cytology, Germany, Distribution Share by Revenue ($mn), 2007-2008 88

Table 49: Immuno Chemistry, Germany, Distribution Share by Revenue ($mn), 2007-2008 89

Table 50: Infectious Immunology, Germany, Distribution Share by Revenue ($mn), 2007-2008 89

Table 51: Microbiology Culture, Germany, Distribution Share by Revenue ($mn), 2007-2008 90

Table 52: In Vitro Diagnostics, Germany, Company Share by Revenue ($ mn), 2007-2008 91

Table 53: Clinical Chemistry, Germany, Company Share by Revenue ($ mn), 2007-2008 92

Table 54: Genetic Testing, Germany, Company Share by Revenue ($ mn), 2007-2008 93

Table 55: Haematology, Germany, Company Share by Revenue ($ mn), 2007-2008 95

Table 56: Histology And Cytology, Germany, Company Share by Revenue ($ mn), 2007-2008 96

Table 57: Immuno Chemistry, Germany, Company Share by Revenue ($ mn), 2007-2008 98

Table 58: Infectious Immunology, Germany, Company Share by Revenue ($ mn), 2007-2008 100

Table 59: Microbiology Culture, Germany, Company Share by Revenue ($ mn), 2007-2008 101

Table 60: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), 2000-2015 102

Table 61: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Historic, 2000-2008 104

Table 62: In Vitro Diagnostics, Italy, Overall Revenue ($ mn), Forecast, 2008-2015 106

Table 63: Clinical Chemistry, Italy, Distribution Share by Revenue ($mn), 2007-2008 107

Table 64: Genetic Testing, Italy, Distribution Share by Revenue ($mn), 2007-2008 107

Table 65: Haematology, Italy, Distribution Share by Revenue ($mn), 2007-2008 108

Table 66: Histology And Cytology, Italy, Distribution Share by Revenue ($mn), 2007-2008 108

Table 67: Immuno Chemistry, Italy, Distribution Share by Revenue ($mn), 2007-2008 109

Table 68: Infectious Immunology, Italy, Distribution Share by Revenue ($mn), 2007-2008 109

Table 69: Microbiology Culture, Italy, Distribution Share by Revenue ($mn), 2007-2008 110

Table 70: In Vitro Diagnostics, Italy, Company Share by Revenue ($ mn), 2007-2008 111

Table 71: Clinical Chemistry, Italy, Company Share by Revenue ($ mn), 2007-2008 112

Table 72: Genetic Testing, Italy, Company Share by Revenue ($ mn), 2007-2008 113

Table 73: Haematology, Italy, Company Share by Revenue ($ mn), 2007-2008 114

Table 74: Histology And Cytology, Italy, Company Share by Revenue ($ mn), 2007-2008 116

Table 75: Immuno Chemistry, Italy, Company Share by Revenue ($ mn), 2007-2008 118

Table 76: Infectious Immunology, Italy, Company Share by Revenue ($ mn), 2007-2008 120

Table 77: Microbiology Culture, Italy, Company Share by Revenue ($ mn), 2007-2008 121

Table 78: In Vitro Diagnostics, France, Overall Revenue ($ mn), 2000-2015 122

Table 79: In Vitro Diagnostics, France, Overall Revenue ($ mn), Historic, 2000-2008 124

Table 80: In Vitro Diagnostics, France, Overall Revenue ($ mn), Forecast, 2008-2015 126

Table 81: Clinical Chemistry, France, Distribution Share by Revenue ($mn), 2007-2008 127

Table 82: Genetic Testing, France, Distribution Share by Revenue ($mn), 2007-2008 127

Table 83: Haematology, France, Distribution Share by Revenue ($mn), 2007-2008 128

Table 84: Histology And Cytology, France, Distribution Share by Revenue ($mn), 2007-2008 128

Table 85: Immuno Chemistry, France, Distribution Share by Revenue ($mn), 2007-2008 129

Table 86: Infectious Immunology, France, Distribution Share by Revenue ($mn), 2007-2008 129

Table 87: Microbiology Culture, France, Distribution Share by Revenue ($mn), 2007-2008 130

Table 88: In Vitro Diagnostics, France, Company Share by Revenue ($ mn), 2007-2008 131

Table 89: Clinical Chemistry, France, Company Share by Revenue ($ mn), 2007-2008 132

Table 90: Genetic Testing, France, Company Share by Revenue ($ mn), 2007-2008 133

Table 91: Haematology, France, Company Share by Revenue ($ mn), 2007-2008 134

Table 92: Histology And Cytology, France, Company Share by Revenue ($ mn), 2007-2008 135

Table 93: Immuno Chemistry, France, Company Share by Revenue ($ mn), 2007-2008 137

Table 94: Infectious Immunology, France, Company Share by Revenue ($ mn), 2007-2008 139

Table 95: Microbiology Culture, France, Company Share by Revenue ($ mn), 2007-2008 140

Table 96: In Vitro Diagnostics, China, Overall Revenue ($ mn), 2000-2015 141

Table 97: In Vitro Diagnostics, China, Overall Revenue ($ mn), Historic, 2000-2008 143

Table 98: In Vitro Diagnostics, China, Overall Revenue ($ mn), Forecast, 2008-2015 145

Table 99: Clinical Chemistry, China, Distribution Share by Revenue ($mn), 2007-2008 146

Table 100: Genetic Testing, China, Distribution Share by Revenue ($mn), 2007-2008 146

Table 101: Haematology, China, Distribution Share by Revenue ($mn), 2007-2008 147

Table 102: Histology And Cytology, China, Distribution Share by Revenue ($mn), 2007-2008 147

Table 103: Immuno Chemistry, China, Distribution Share by Revenue ($mn), 2007-2008 148

Table 104: Infectious Immunology, China, Distribution Share by Revenue ($mn), 2007-2008 148

Table 105: Microbiology Culture, China, Distribution Share by Revenue ($mn), 2007-2008 149

Table 106: In Vitro Diagnostics, China, Company Share by Revenue ($ mn), 2007-2008 150

Table 107: Clinical Chemistry, China, Company Share by Revenue ($ mn), 2007-2008 152

Table 108: Genetic Testing, China, Company Share by Revenue ($ mn), 2007-2008 153

Table 109: Haematology, China, Company Share by Revenue ($ mn), 2007-2008 154

Table 110: Histology And Cytology, China, Company Share by Revenue ($ mn), 2007-2008 155

Table 111: Immuno Chemistry, China, Company Share by Revenue ($ mn), 2007-2008 157

Table 112: Infectious Immunology, China, Company Share by Revenue ($ mn), 2007-2008 159

Table 113: Microbiology Culture, China, Company Share by Revenue ($ mn), 2007-2008 160

Table 114: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), 2000-2015 161

Table 115: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Historic, 2000-2008 163

Table 116: In Vitro Diagnostics, Spain, Overall Revenue ($ mn), Forecast, 2008-2015 165

Table 117: Clinical Chemistry, Spain, Distribution Share by Revenue ($mn), 2007-2008 166

Table 118: Genetic Testing, Spain, Distribution Share by Revenue ($mn), 2007-2008 166

Table 119: Haematology, Spain, Distribution Share by Revenue ($mn), 2007-2008 167

Table 120: Histology and Cytology, Spain, Distribution Share by Revenue ($mn), 2007-2008 167

Table 121: Immuno Chemistry, Spain, Distribution Share by Revenue ($mn), 2007-2008 168

Table 122: Infectious Immunology, Spain, Distribution Share by Revenue ($mn), 2007-2008 168

Table 123: Microbiology Culture, Spain, Distribution Share by Revenue ($mn), 2007-2008 169

Table 124: In Vitro Diagnostics, Spain, Company Share by Revenue ($ mn), 2007-2008 170

Table 125: Clinical Chemistry, Spain, Company Share by Revenue ($ mn), 2007-2008 171

Table 126: Genetic Testing, Spain, Company Share by Revenue ($ mn), 2007-2008 172

Table 127: Haematology, Spain, Company Share by Revenue ($ mn), 2007-2008 173

Table 128: Histology and Cytology, Spain, Company Share by Revenue ($ mn), 2007-2008 174

Table 129: Immuno Chemistry, Spain, Company Share by Revenue ($ mn), 2007-2008 176

Table 130: Infectious Immunology, Spain, Company Share by Revenue ($ mn), 2007-2008 178

Table 131: Microbiology Culture, Spain, Company Share by Revenue ($ mn), 2007-2008 179

Table 132: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), 2000-2015 180

Table 133: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Historic, 2000-2008 182

Table 134: In Vitro Diagnostics, United Kingdom, Overall Revenue ($ mn), Forecast, 2008-2015 184

Table 135: Clinical Chemistry, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 185

Table 136: Genetic Testing, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 185

Table 137: Haematology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 186

Table 138: Histology and Cytology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 186

Table 139: Immuno Chemistry, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 187

Table 140: Infectious Immunology, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 187

Table 141: Microbiology Culture, United Kingdom, Distribution Share by Revenue ($mn), 2007-2008 188

Table 142: In Vitro Diagnostics, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 189

Table 143: Clinical Chemistry, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 190

Table 144: Genetic Testing, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 191

Table 145: Haematology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 193

Table 146: Histology and Cytology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 195

Table 147: Immuno Chemistry, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 197

Table 148: Infectious Immunology, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 199

Table 149: Microbiology Culture, United Kingdom, Company Share by Revenue ($ mn), 2007-2008 200

Table 150: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), 2000-2015 201

Table 151: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Historic, 2000-2008 203

Table 152: In Vitro Diagnostics, Brazil, Overall Revenue ($ mn), Forecast, 2008-2015 205

Table 153: Clinical Chemistry, Brazil, Distribution Share by Revenue ($mn), 2007-2008 206

Table 154: Genetic Testing, Brazil, Distribution Share by Revenue ($mn), 2007-2008 206

Table 155: Haematology, Brazil, Distribution Share by Revenue ($mn), 2007-2008 207

Table 156: Histology And Cytology, Brazil, Distribution Share by Revenue ($mn), 2007-2008 207

Table 157: Immuno Chemistry, Brazil, Distribution Share by Revenue ($mn), 2007-2008 208

Table 158: Infectious Immunology, Brazil, Distribution Share by Revenue ($mn), 2007-2008 208

Table 159: Microbiology Culture, Brazil, Distribution Share by Revenue ($mn), 2007-2008 209

Table 160: In Vitro Diagnostics, Brazil, Company Share by Revenue ($ mn), 2007-2008 210

Table 161: Clinical Chemistry, Brazil, Company Share by Revenue ($ mn), 2007-2008 211

Table 162: Genetic Testing, Brazil, Company Share by Revenue ($ mn), 2007-2008 212

Table 163: Haematology, Brazil, Company Share by Revenue ($ mn), 2007-2008 213

Table 164: Histology And Cytology, Brazil, Company Share by Revenue ($ mn), 2007-2008 214

Table 165: Immuno Chemistry, Brazil, Company Share by Revenue ($ mn), 2007-2008 216

Table 166: Infectious Immunology, Brazil, Company Share by Revenue ($ mn), 2007-2008 218

Table 167: Microbiology Culture, Brazil, Company Share by Revenue ($ mn), 2007-2008 219

Table 168: In Vitro Diagnostics, Canada, Overall Revenue ($ mn), 2000-2015 220

Table 169: In Vitro Diagnostics, Canada, Overall Revenue ($ mn), Historic, 2000-2008 222

Table 170: In Vitro Diagnostics, Canada, Overall Revenue ($ mn), Forecast, 2008-2015 224

Table 171: Clinical Chemistry, Canada, Distribution Share by Revenue ($mn), 2007-2008 225

Table 172: Genetic Testing, Canada, Distribution Share by Revenue ($mn), 2007-2008 225

Table 173: Haematology, Canada, Distribution Share by Revenue ($mn), 2007-2008 226

Table 174: Histology And Cytology, Canada, Distribution Share by Revenue ($mn), 2007-2008 226

Table 175: Immuno Chemistry, Canada, Distribution Share by Revenue ($mn), 2007-2008 227

Table 176: Infectious Immunology, Canada, Distribution Share by Revenue ($mn), 2007-2008 227

Table 177: Microbiology Culture, Canada, Distribution Share by Revenue ($mn), 2007-2008 228

Table 178: In Vitro Diagnostics, Canada, Company Share by Revenue ($ mn), 2007-2008 229

Table 179: Clinical Chemistry, Canada, Company Share by Revenue ($ mn), 2007-2008 230

Table 180: Genetic Testing, Canada, Company Share by Revenue ($ mn), 2007-2008 231

Table 181: Haematology, Canada, Company Share by Revenue ($ mn), 2007-2008 232

Table 182: Histology And Cytology, Canada, Company Share by Revenue ($ mn), 2007-2008 233

Table 183: Immuno Chemistry, Canada, Company Share by Revenue ($ mn), 2007-2008 235

Table 184: Infectious Immunology, Canada, Company Share by Revenue ($ mn), 2007-2008 237

Table 185: Microbiology Culture, Canada, Company Share by Revenue ($ mn), 2007-2008 238

Table 186: In Vitro Diagnostics, India, Overall Revenue ($ mn), 2000-2015 239

Table 187: In Vitro Diagnostics, India, Overall Revenue ($ mn), Historic, 2000-2008 241

Table 188: In Vitro Diagnostics, India, Overall Revenue ($ mn), Forecast, 2008-2015 243

Table 189: Clinical Chemistry, India, Distribution Share by Revenue ($mn), 2007-2008 244

Table 190: Genetic Testing, India, Distribution Share by Revenue ($mn), 2007-2008 244

Table 191: Haematology, India, Distribution Share by Revenue ($mn), 2007-2008 245

Table 192: Histology And Cytology, India, Distribution Share by Revenue ($mn), 2007-2008 245

Table 193: Immuno Chemistry, India, Distribution Share by Revenue ($mn), 2007-2008 246

Table 194: Infectious Immunology, India, Distribution Share by Revenue ($mn), 2007-2008 246

Table 195: Microbiology Culture, India, Distribution Share by Revenue ($mn), 2007-2008 247

Table 196: In Vitro Diagnostics, India, Company Share by Revenue ($ mn), 2007-2008 248

Table 197: Clinical Chemistry, India, Company Share by Revenue ($ mn), 2007-2008 250

Table 198: Genetic Testing, India, Company Share by Revenue ($ mn), 2007-2008 251

Table 199: Haematology, India, Company Share by Revenue ($ mn), 2007-2008 252

Table 200: Histology And Cytology, India, Company Share by Revenue ($ mn), 2007-2008 253

Table 201: Immuno Chemistry, India, Company Share by Revenue ($ mn), 2007-2008 255

Table 202: Infectious Immunology, India, Company Share by Revenue ($ mn), 2007-2008 257

Table 203: Microbiology Culture, India, Company Share by Revenue ($ mn), 2007-2008 259

Table 204: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), 2000-2015 260

Table 205: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Historic, 2000-2008 262

Table 206: In Vitro Diagnostics, Australia, Overall Revenue ($ mn), Forecast, 2008-2015 264

Table 207: Clinical Chemistry, Australia, Distribution Share by Revenue ($mn), 2007-2008 265

Table 208: Genetic Testing, Australia, Distribution Share by Revenue ($mn), 2007-2008 265

Table 209: Haematology, Australia, Distribution Share by Revenue ($mn), 2007-2008 266

Table 210: Histology And Cytology, Australia, Distribution Share by Revenue ($mn), 2007-2008 266

Table 211: Immuno Chemistry, Australia, Distribution Share by Revenue ($mn), 2007-2008 267

Table 212: Infectious Immunology, Australia, Distribution Share by Revenue ($mn), 2007-2008 267

Table 213: Microbiology Culture, Australia, Distribution Share by Revenue ($mn), 2007-2008 268

Table 214: In Vitro Diagnostics, Australia, Company Share by Revenue ($ mn), 2007-2008 269

Table 215: Clinical Chemistry, Australia, Company Share by Revenue ($ mn), 2007-2008 270

Table 216: Genetic Testing, Australia, Company Share by Revenue ($ mn), 2007-2008 271

Table 217: Haematology, Australia, Company Share by Revenue ($ mn), 2007-2008 272

Table 218: Histology And Cytology, Australia, Company Share by Revenue ($ mn), 2007-2008 273

Table 219: Immuno Chemistry, Australia, Company Share by Revenue ($ mn), 2007-2008 275

Table 220: Infectious Immunology, Australia, Company Share by Revenue ($ mn), 2007-2008 277

Table 221: Microbiology Culture, Australia, Company Share by Revenue ($ mn), 2007-2008 278

Table 222: Sysmex Corporation Pipeline Products by Equipment Type 280

Table 223: Sysmex Corporation Pipeline Products By Development Stage 280

Table 224: Sysmex Corporation Pipeline Products By Therapy Area 280

Table 225: Sysmex Corporation Pipeline Products By News Summary 281

Table 226: Abbott Laboratories Pipeline Products by Equipment Type 282

Table 227: Abbott Laboratories Pipeline Products By Development Stage 282

Table 228: Abbott Laboratories Pipeline Products By Therapy Area 282

Table 229: Beckman Coulter, Inc. Pipeline Products by Equipment Type 283

Table 230: Beckman Coulter, Inc. Pipeline Products By Development Stage 284

Table 231: Beckman Coulter, Inc. Pipeline Products By Therapy Area 285

Table 232: Beckman Coulter, Inc. Pipeline Products By News Summary 285

Table 233: Ortho-Clinical Diagnostics Inc. Pipeline Products by Equipment Type 286

Table 234: Ortho-Clinical Diagnostics Inc. Pipeline Products By Development Stage 287

Table 235: Ortho-Clinical Diagnostics Inc. Pipeline Products By Therapy Area 287

Table 236: Phadia AB Pipeline Products by Equipment Type 290

Table 237: Phadia AB Pipeline Products By Development Stage 290

Table 238: Phadia AB Pipeline Products By Therapy Area 291

Table 239: Phadia AB Pipeline Products By News Summary 291

Table 240: DiaSorin S.p.A Pipeline Products by Equipment Type 292

Table 241: DiaSorin S.p.A Pipeline Products By Development Stage 292

Table 242: DiaSorin S.p.A Pipeline Products By Therapy Area 292

Table 243: Gen-Probe Incorporated Pipeline Products by Equipment Type 294

Table 244: Gen-Probe Incorporated Pipeline Products By Development Stage 295

Table 245: Gen-Probe Incorporated Pipeline Products By Therapy Area 295

Table 246: Gen-Probe Incorporated Pipeline Products By Clinical Trials 295

Table 247: Gen-Probe Incorporated Pipeline Products By News Summary 296

Table 248: Inverness Medical Innovations, Inc. Pipeline Products by Equipment Type 297

Table 249: Inverness Medical Innovations, Inc. Pipeline Products By Development Stage 298

Table 250: Inverness Medical Innovations, Inc. Pipeline Products By Therapy Area 298

Table 251: Inverness Medical Innovations, Inc. Pipeline Products By Clinical Trials 298

Table 252: Inverness Medical Innovations, Inc. Pipeline Products By News Summary 299

Table 253: Calypte Biomedical Corporation Pipeline Products by Equipment Type 302

Table 254: Calypte Biomedical Corporation Pipeline Products By Development Stage 302

Table 255: Calypte Biomedical Corporation Pipeline Products By Therapy Area 302

Table 256: Calypte Biomedical Corporation Pipeline Products By News Summary 303

Table 257: CytoCore, Inc. Pipeline Products by Equipment Type 304

Table 258: CytoCore, Inc. Pipeline Products By Development Stage 305

Table 259: CytoCore, Inc. Pipeline Products By Therapy Area 305

Table 260: CytoCore, Inc. Pipeline Products By Clinical Trials 305

Table 261: Daxor Corporation Pipeline Products by Equipment Type 306

Table 262: Daxor Corporation Pipeline Products By Development Stage 306

Table 263: Daxor Corporation Pipeline Products By Therapy Area 307

Table 264: IRIS International, Inc. Pipeline Products by Equipment Type 308

Table 265: IRIS International, Inc. Pipeline Products By Development Stage 308

Table 266: IRIS International, Inc. Pipeline Products By Therapy Area 309

Table 267: IRIS International, Inc. Pipeline Products By News Summary 309

Table 268: Onconome, Inc. Pipeline Products by Equipment Type 310

Table 269: Onconome, Inc. Pipeline Products By Development Stage 310

Table 270: Onconome, Inc. Pipeline Products By Therapy Area 310

Table 271: Onconome, Inc. Pipeline Products By Clinical Trials 311

Table 272: Onconome, Inc. Pipeline Products By News Summary 311

Table 273: Targeted Diagnostics & Therapeutics, Inc. Pipeline Products by Equipment Type 312

Table 274: Targeted Diagnostics & Therapeutics, Inc. Pipeline Products By Development Stage 312

Table 275: Targeted Diagnostics & Therapeutics, Inc. Pipeline Products By Therapy Area 313

Table 276: Targeted Diagnostics & Therapeutics, Inc. Pipeline Products By News Summary 313

Table 277: American Bio Medica Corporation Pipeline Products by Equipment Type 315

Table 278: American Bio Medica Corporation Pipeline Products By Development Stage 315

Table 279: American Bio Medica Corporation Pipeline Products By Therapy Area 316

Table 280: American Bio Medica Corporation Pipeline Products By News Summary 316

Table 281: Laboratory Corporation of America Holdings Pipeline Products by Equipment Type 317

Table 282: Laboratory Corporation of America Holdings Pipeline Products By Development Stage 318

Table 283: Laboratory Corporation of America Holdings Pipeline Products By Therapy Area 318

Table 284: Laboratory Corporation of America Holdings Pipeline Products By News Summary 318

Table 285: American Diagnostica Inc. Pipeline Products by Equipment Type 319

Table 286: American Diagnostica Inc. Pipeline Products By Development Stage 319

Table 287: American Diagnostica Inc. Pipeline Products By Therapy Area 319

Table 288: GRANT Life Sciences, Inc. Pipeline Products by Equipment Type 320

Table 289: GRANT Life Sciences, Inc. Pipeline Products By Development Stage 320

Table 290: GRANT Life Sciences, Inc. Pipeline Products By Therapy Area 321

Table 291: GRANT Life Sciences, Inc. Pipeline Products By News Summary 321

Table 292: Luminex Corporation Pipeline Products by Equipment Type 322

Table 293: Luminex Corporation Pipeline Products By Development Stage 323

Table 294: Luminex Corporation Pipeline Products By Therapy Area 323

Table 295: Akonni Biosystems Inc Pipeline Products by Equipment Type 324

Table 296: Akonni Biosystems Inc Pipeline Products By Development Stage 324

Table 297: Akonni Biosystems Inc Pipeline Products By Therapy Area 325

Table 298: Progentech USA, Inc. Pipeline Products by Equipment Type 326

Table 299: Progentech USA, Inc. Pipeline Products By Development Stage 326

Table 300: Progentech USA, Inc. Pipeline Products By Therapy Area 326

Table 301: Source MDx Pipeline Products by Equipment Type 327

Table 302: Source MDx Pipeline Products By Development Stage 328

Table 303: Source MDx Pipeline Products By Therapy Area 329

Table 304: Source MDx Pipeline Products By Clinical Trials 329

Table 305: Eiken Chemical Co.,Ltd. Pipeline Products by Equipment Type 331

Table 306: Eiken Chemical Co.,Ltd. Pipeline Products By Development Stage 331

Table 307: Eiken Chemical Co.,Ltd. Pipeline Products By Therapy Area 331

Table 308: China Medical Technologies, Inc. Pipeline Products by Equipment Type 333

Table 309: China M

To order this report:

Global In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015

http://www.reportlinker.com/p0164632/Global-In-Vitro-Diagnostics-Investment-Opportunities-Analysis-and-Forecasts-to-2015.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

More market research reports here!

    CONTACT:
    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds European Markets for Spinal Implants, MIS, and VCF 2009 (15 Countries)
2. Reportlinker Adds Audiological Devices - Global Market Trends
3. Reportlinker Adds U.S. Market for Small Bone & Joint Orthopedic Devices 2009
4. Reportlinker Adds European Markets for Orthopedic Biomaterials 2009 (15 Countries)
5. Reportlinker Adds Brazil, Russian, Indian and Chinese Markets for Endoscopic Devices 2009 (4 Countries)
6. Reportlinker Adds US Orthopedic Devices Market Analysis & Forecasts to 2015
7. Reportlinker Adds United States Medical Equipment Market Analysis & Forecasts to 2015
8. Reportlinker Adds Metabolic Endocrinology Hypocalcemia
9. Reportlinker Adds Injectable Drug Delivery: Market Impact and Industry Trends
10. Reportlinker Adds The Future of the Wound Care Management Market to 2015
11. Reportlinker Adds The Prescribing Data Restriction Program: Critical Assessment and Best Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
Breaking Medicine News(10 mins):